CA-125对ICU机械通气患者拔管后发生呼吸衰竭诊断的预测价值
Predictive Value of CA-125 for the Diagnosis of Post-Extubation Respiratory Failure in Mechanically Ventilated ICU Patients
DOI: 10.12677/jcpm.2026.51043, PDF,   
作者: 赵常宏, 常晨铭:济宁医学院临床医学院(附属医院),山东 济宁;李文强*:济宁市第一人民医院重症医学科,山东 济宁
关键词: 机械通气CA-125重症监护病房呼吸衰竭成年人预测Mechanical Ventilation CA-125 Intensive Care Unit Respiratory Failure Adults Prediction
摘要: 目的:评估CA-125对ICU机械通气患者在拔管后发生呼吸衰竭的诊断和预测价值。方法:纳入2024年8月至2025年7月在济宁市第一人民医院ICU住院的机械通气患者164例。根据撤机结果将患者分为撤机成功组(n = 134)和撤机失败组(n = 30),比较两组的临床资料。采用多因素Logistic回归分析探讨成人ICU机械通气患者在撤机后出现呼吸衰竭的影响因素。采用ROC曲线评估CA-125及其正常值范围对成人ICU机械通气患者撤机后出现呼吸衰竭的预测价值。此外,以CA-125为分界指标,将患者分为CA-125 < 42.25组(n = 113)和CA-125 ≥ 42.25组(n = 51),比较不同CA-125水平患者的机械通气时间和住院时间。结果:撤机成功组入ICU时的APACHEII评分、SOFA评分、CA-125水平及RSBI均低于撤机失败组(P < 0.05)。多因素Logistic回归分析结果显示,通过SBT试验后进行拔管时的CA-125水平是成人ICU机械通气患者撤机后出现呼吸衰竭的独立影响因素(P < 0.05)。ROC曲线分析结果显示,通过SBT试验后进行拔管时CA-125预测成人ICU机械通气患者撤机后出现呼吸衰竭的AUC为0.752 [95% CI (0.628, 0.862)],对应Youden指数最大的截断值为42.25 UI/ml,灵敏度为0.767,特异度为0.784。将CA-125固定为35.00 UI/ml时,其预测成人ICU机械通气患者撤机后出现呼吸衰竭的AUC为0.743 [95% CI (0.658, 0.823)],灵敏度为0.800,特异度为0.687。按CA-125分层比较,CA-125 < 42.25组的机械通气时间和住院时间均长于CA-125 ≥ 42.25组,差异具有统计学意义(P < 0.05)。结论:CA-125对成人ICU机械通气患者撤机后出现呼吸衰竭有一定预测效能。
Abstract: Objective: To evaluate the diagnostic and predictive value of CA-125 for post-extubation respiratory failure in mechanically ventilated ICU patients. Methods: We enrolled 164 mechanically ventilated patients admitted to the ICU of Jining First People’s Hospital from August 2024 to July 2025. Based on weaning outcomes, patients were classified into a weaning-success group (n = 134) and a weaning-failure group (n = 30), and clinical characteristics were compared between groups. Multivariable logistic regression was used to examine factors associated with post-weaning respiratory failure in adult ICU patients receiving mechanical ventilation. Receiver operating characteristic (ROC) curves were applied to assess the predictive value of CA-125 and its normal reference range for post-weaning respiratory failure in this population. In addition, using CA-125 as the stratification threshold, patients were divided into a CA-125 < 42.25 group (n = 113) and a CA-125 ≥ 42.25 group (n = 51), and mechanical ventilation duration and hospital length of stay were compared between the two groups. Results: At ICU admission, the weaning-success group had lower APACHE II scores, SOFA scores, CA-125 levels, and RSBI values than the weaning-failure group (P < 0.05). In multivariable logistic regression, the CA-125 level at the time of extubation following a successful spontaneous breathing trial (SBT) was an independent factor associated with post-weaning respiratory failure in mechanically ventilated adult ICU patients (P < 0.05). Receiver operating characteristic (ROC) analysis showed that CA-125 measured at extubation after SBT predicted post-extubation respiratory failure with an AUC of 0.752 (95% CI, 0.628~0.862); the cutoff corresponding to the maximal Youden index was 42.25 U/mL, with a sensitivity of 0.767 and a specificity of 0.784. Using a fixed CA-125 threshold of 35.00 U/mL yielded an AUC of 0.743 (95% CI, 0.658~0.823), with a sensitivity of 0.800 and a specificity of 0.687. When stratified by CA-125, patients with CA-125 < 42.25 had longer durations of mechanical ventilation and hospital stay than those with CA-125 ≥ 42.25 (P < 0.05). Conclusion: CA-125 demonstrates predictive utility for identifying post-extubation respiratory failure among mechanically ventilated adult ICU patients.
文章引用:赵常宏, 常晨铭, 李文强. CA-125对ICU机械通气患者拔管后发生呼吸衰竭诊断的预测价值[J]. 临床个性化医学, 2026, 5(1): 297-304. https://doi.org/10.12677/jcpm.2026.51043

参考文献

[1] Khan, W., Safi, A., Muneeb, M., Mooghal, M., Aftab, A. and Ahmed, J. (2022) Complications of Invasive Mechanical Ventilation in Critically Ill COVID-19 Patients—A Narrative Review. Annals of Medicine & Surgery, 80, Article 104201. [Google Scholar] [CrossRef] [PubMed]
[2] Bureau, C., Van Hollebeke, M. and Dres, M. (2023) Managing Respiratory Muscle Weakness during Weaning from Invasive Ventilation. European Respiratory Review, 32, Article 220205. [Google Scholar] [CrossRef] [PubMed]
[3] Huang, H., Huang, C. and Li, L. (2022) Prolonged Mechanical Ventilation: Outcomes and Management. Journal of Clinical Medicine, 11, Article 2451. [Google Scholar] [CrossRef] [PubMed]
[4] Rouzé, A., Cottereau, A. and Nseir, S. (2014) Chronic Obstructive Pulmonary Disease and the Risk for Ventilator-Associated Pneumonia. Current Opinion in Critical Care, 20, 525-531. [Google Scholar] [CrossRef] [PubMed]
[5] Varón-Vega, F., Tuta-Quintero, E., Robayo-Amortegui, H., Rincón, A., Giraldo-Cadavid, L.F., Palacios, J., et al. (2025) Clinical Utility of Rapid Shallow Breathing Index in Predicting Successful Weaning: Secondary Analysis of the COBRE-US Trial. Medicina Intensiva, 49, 72-77. [Google Scholar] [CrossRef
[6] Song, J., Qian, Z., Zhang, H., Wang, M., Yu, Y., Ye, C., et al. (2022) Diaphragmatic Ultrasonography-Based Rapid Shallow Breathing Index for Predicting Weaning Outcome during a Pressure Support Ventilation Spontaneous Breathing Trial. BMC Pulmonary Medicine, 22, Article No. 337. [Google Scholar] [CrossRef] [PubMed]
[7] Thériault, C., Pinard, M., Comamala, M., Migneault, M., Beaudin, J., Matte, I., et al. (2011) MUC16 (CA125) Regulates Epithelial Ovarian Cancer Cell Growth, Tumorigenesis and Metastasis. Gynecologic Oncology, 121, 434-443. [Google Scholar] [CrossRef] [PubMed]
[8] Marinescu, M.C., Oprea, V.D., Munteanu, S.N., Nechita, A., Tutunaru, D., Nechita, L.C., et al. (2024) Carbohydrate Antigen 125 (CA 125): A Novel Biomarker in Acute Heart Failure. Diagnostics, 14, Article 795. [Google Scholar] [CrossRef] [PubMed]
[9] Separham, A., Abbasnezhad, M., Shahnazarli, G. and Khoshbahar, A. (2018) Role of Plasma Levels of CA-125 in Predicting Outcome of Primary PCI after Acute Myocardial Infarction in Male Patients. Journal of Cardiovascular and Thoracic Research, 10, 109-112. [Google Scholar] [CrossRef] [PubMed]
[10] Riccardi, M., Cikes, M., Adamo, M., Pagnesi, M., Lombardi, C.M., Solomon, S.D., et al. (2024) Functional Mitral Regurgitation and Heart Failure with Preserved Ejection Fraction: Clinical Implications and Management. Journal of Cardiac Failure, 30, 929-939. [Google Scholar] [CrossRef] [PubMed]
[11] Falco, L., Martucci, M.L., Valente, F., Verrengia, M., Pacileo, G. and Masarone, D. (2023) Pathophysiology-Based Management of Acute Heart Failure. Clinics and Practice, 13, 206-218. [Google Scholar] [CrossRef] [PubMed]
[12] Alfaro, E., Díaz-García, E., García-Tovar, S., Galera, R., Casitas, R., Torres-Vargas, M., et al. (2024) Endothelial Dysfunction and Persistent Inflammation in Severe Post-COVID-19 Patients: Implications for Gas Exchange. BMC Medicine, 22, Article No. 242. [Google Scholar] [CrossRef] [PubMed]
[13] Knox, K.E., Hotz, J.C., Newth, C.J.L., Khoo, M.C.K. and Khemani, R.G. (2023) A 30-Minute Spontaneous Breathing Trial Misses Many Children Who Go on to Fail a 120-Minute Spontaneous Breathing Trial. CHEST, 163, 115-127. [Google Scholar] [CrossRef] [PubMed]
[14] Liang, G., Liu, T., Zeng, Y., Shi, Y., Yang, W., Yang, Y., et al. (2018) Characteristics of Subjects Who Failed a 120-Minute Spontaneous Breathing Trial. Respiratory Care, 63, 388-394. [Google Scholar] [CrossRef] [PubMed]
[15] Spagnol, G., Marchetti, M., Carollo, M., Bigardi, S., Tripepi, M., Facchetti, E., et al. (2024) Clinical Utility and Diagnostic Accuracy of ROMA, RMI, ADNEX, HE4, and CA125 in the Prediction of Malignancy in Adnexal Masses. Cancers, 16, Article 3790. [Google Scholar] [CrossRef] [PubMed]
[16] Palisciano, M., Terrinoni, M., Napoleoni, E., Adinolfi, F., Rossetti, D. and Di Renzo, G.C. (2025) Benign Serous Cystadenofibroma with Multimodal Imaging Suggestive of Malignancy in a Symptomatic Postmenopausal Patient. Menopausal Review, 24, 221-224. [Google Scholar] [CrossRef
[17] Frigy, A., Belényi, B., Kirchmaier, Á., Fekete, N. and Szabó, I.A. (2020) Elevated CA-125 as Humoral Biomarker of Congestive Heart Failure: Illustrative Cases and a Short Review of Literature. Case Reports in Cardiology, 2020, Article ID: 1642914. [Google Scholar] [CrossRef] [PubMed]
[18] Pinheiro, J.L., Duarte, L., Santos, A.J., Tojal, A., Canhoto, C., Ferreira, M., et al. (2023) Predicting Peritoneal Carcinomatosis in Locally Advanced Gastric Cancer: The Significance of Tumor Markers in the Peritoneal Washing. Journal of Gastrointestinal Cancer, 55, 427-434. [Google Scholar] [CrossRef] [PubMed]
[19] Vecchi, A., Muccioli, S., Marazzato, J., Mancinelli, A., Iacovoni, A. and De Ponti, R. (2021) Prognostic Role of Subclinical Congestion in Heart Failure Outpatients: Focus on Right Ventricular Dysfunction. Journal of Clinical Medicine, 10, Article 5423. [Google Scholar] [CrossRef] [PubMed]
[20] Kaya, H., Zorlu, A., Yucel, H., Dogan, O.T., Sarikaya, S., Aydin, G., et al. (2015) Cancer Antigen-125 Levels Predict Long-Term Mortality in Chronic Obstructive Pulmonary Disease. Biomarkers, 20, 162-167. [Google Scholar] [CrossRef] [PubMed]
[21] Tan, Q., Xu, L.F., Yan, T., Huang, C.H., Tao, Y., Huang, W.H., et al. (2023) Deciphering the Puzzle: A Case Report of Tjalma Syndrome (Pseudo-Pseudo Meigs’ Syndrome) with Profoundly Elevated CA-125 and Pleural Effusion. Frontiers in Immunology, 14, Article ID: 1277683. [Google Scholar] [CrossRef] [PubMed]
[22] Llàcer, P., Bayés-Genís, A. and Núñez, J. (2019) Carbohydrate Antigen 125 in Heart Failure. a New Era in the Monitoring and Control of Treatment. Medicina Clínica (English Edition), 152, 266-273. [Google Scholar] [CrossRef
[23] Llàcer, P., Gallardo, M.Á., Palau, P., Moreno, M.C., Castillo, C., Fernández, C., et al. (2021) Comparison between CA125 and NT-ProBNP for Evaluating Congestion in Acute Heart Failure. Medicina Clínica (English Edition), 156, 589-594. [Google Scholar] [CrossRef
[24] Goryacheva, O.A., Ponomaryova, T.D., Drozd, D.D., Kokorina, A.A., Rusanova, T.Y., Mishra, P.K., et al. (2022) Heart Failure Biomarkers BNP and Nt-Probnp Detection Using Optical Labels. TrAC Trends in Analytical Chemistry, 146, Article 116477. [Google Scholar] [CrossRef
[25] Ferreira, J.P., Packer, M., Sattar, N., Butler, J., Pocock, S.J., Anker, S.D., et al. (2024) Carbohydrate Antigen 125 Concentrations across the Ejection Fraction Spectrum in Chronic Heart Failure: The emperor Programme. European Journal of Heart Failure, 26, 788-802. [Google Scholar] [CrossRef] [PubMed]